FENC

Fennec Pharmaceuticals Inc. · NASDAQ

Sector Health Technology
Industry Pharmaceuticals: Major
Website fennecpharma.com
Employees(FY) 36
ISIN CA31447P1009

Performance

-1.96%

+40.12%

+13.23%

-9.92%

-46.61%

YTD

-42.29%

Profile

Fennec Pharmaceuticals Inc. operates as a biopharmaceutical company. The company's product candidates include PEDMARK, a formulation of sodium thiosulfate for the prevention of platinum-induced ototoxicity hearing loss in pediatric cancer patients. It sells its products through regional pediatric oncology specialists and medical science liaisons. The company was formerly known as Adherex Technologies Inc. and changed its name to Fennec Pharmaceuticals Inc. in September 2014. Fennec Pharmaceuticals Inc. was incorporated in 1996 and is based in Research Triangle Park, North Carolina.

Advanced Technical Analysis

Technical Analysis of FENC 2024-12-20

The Moving Average Score of 70 indicates a strong bullish sentiment, while the Technical Score of 60 also reflects a positive outlook; however, the Oscillators Score of 50 suggests a neutral stance. Overall, the combined scores imply a generally bullish sentiment in the stock, with some caution advised due to the neutral oscillator reading.

Technical Scores and Rating

Moving Average Score

Oscillator Score

Technical Rating

Stock Analysis of FENC

Stock Rank

Recent News & Updates

2024-12-19 17:16
Fennec Pharmaceuticals Announces Pedmarqsi Positive Recommendation by NICE for the Prevention of Cisplatin-Induced Hearing Loss in England and Wales(Globenewswire)
2024-12-18 17:13
Fennec Pharmaceuticals Announces Early Partial Repayment of Its Outstanding Convertible Debt Facility with Petrichor Healthcare Capital Management(Globenewswire)
2024-12-11 18:01
Fennec Pharmaceuticals to Participate in Upcoming Investor Conference(Globenewswire)
2024-11-12 17:27
Fennec Pharmaceuticals to Participate in Upcoming Investor Conference(Globenewswire)
2024-11-08 13:00
Fennec Pharmaceuticals Inc (FENC) Q3 2024 Earnings Call Highlights: Strong Sales Growth and ...(Yahoo Finance)
2024-11-06 17:13
Fennec Pharmaceuticals Reports Third Quarter 2024 Financial Results and Provides Business Update(Globenewswire)
2024-10-30 18:23
Fennec Pharmaceuticals to Report Third Quarter 2024 Financial Results on November 7, 2024(Globenewswire)
2024-10-27 18:23
Fennec Pharmaceuticals Strengthens Executive Leadership Team with Three Key Appointments to Accelerate the Company's Next Stage of Growth(Globenewswire)
2024-09-04 18:56
Fennec Pharmaceuticals to Participate in Upcoming Investor Conferences(Globenewswire)
2024-08-13 13:57
Q2 2024 Fennec Pharmaceuticals Inc Earnings Call(Yahoo Finance)
2024-08-12 18:05
Fennec Pharmaceuticals Reports Second Quarter 2024 Financial Results and Provides Business Update(Globenewswire)
2024-08-06 04:31
Fennec Pharmaceuticals to Report Second Quarter 2024 Financial Results on August 13, 2024(Globenewswire)
2024-08-04 18:26
Fennec Pharmaceuticals Appoints Jeffrey S. Hackman as Chief Executive Officer and Director(Globenewswire)
2024-07-28 18:15
3 Dirt-Cheap Stocks Under $10 That Could EXPLODE!(Yahoo Finance)
2024-07-14 20:32
Implied Volatility Surging for Fennec (FENC) Stock Options(Zacks)
2024-06-30 18:00
Fennec Pharmaceuticals Announces Management Change(Globenewswire)
2024-06-25 04:35
Fennec Announces Results of Annual Meeting(Globenewswire)
2024-05-14 20:44
HC Wainwright Adjusts Fennec Pharmaceuticals Price Target to $15 From $18, Maintains Buy Rating(Yahoo Finance)
2024-05-13 22:53
FENC Stock Earnings: Fennec Pharmaceuticals Beats EPS, Beats Revenue for Q1 2024(Investorplace)
2024-05-13 19:20
Fennec Pharmaceuticals Swings to Q1 Profit on Higher Sales, Licensing Revenue(Yahoo Finance)
2024-05-13 18:03
Fennec Pharmaceuticals Reports First Quarter 2024 Financial Results and Provides Business Update(Globenewswire)
2024-05-07 06:15
Fennec Pharmaceuticals to Report First Quarter 2024 Financial Results on May 14, 2024(Globenewswire)
2024-04-22 20:01
Fennec Pharmaceuticals Insider Sold Shares Worth $414,472, According to a Recent SEC Filing(Yahoo Finance)
2024-04-05 07:00
Insider Sell: CEO Rosty Raykov Sells 88,583 Shares of Fennec Pharmaceuticals Inc (FENC)(Yahoo Finance)
2024-03-27 07:00
Chief Financial Officer Robert Andrade Sells 13,975 Shares of Fennec Pharmaceuticals Inc (FENC)(Yahoo Finance)
2024-03-25 13:00
Chief Financial Officer Robert Andrade Sells Shares of Fennec Pharmaceuticals Inc (FENC)(Yahoo Finance)
2024-03-21 21:49
Fennec Pharmaceuticals Inc. (NASDAQ:FENC) Q4 2023 Earnings Call Transcript(Insidermonkey)
2024-03-21 17:04
Q4 2023 Fennec Pharmaceuticals Inc Earnings Call(Yahoo Finance)
2024-03-21 02:52
FENC Stock Earnings: Fennec Pharmaceuticals Misses EPS, Beats Revenue for Q4 2023(Investorplace)
2024-03-20 18:00
Fennec Pharmaceuticals Reports Full Year and Fourth Quarter 2023 Financial Results and Provides Business Update(Globenewswire)

Page 1 of 5

previousnext

Disclaimer: The information provided here and on kavout.com site is for general informational purposes only. It does not constitute investment advice, financial advice, trading advice, or any other sort of advice. Kavout does not recommend that any investment decision be made based on this information. You are solely responsible for your own investment decisions. Please conduct your own research and consult with qualified financial advisors before making any investment. Kavout and its partners are participants in a number of affiliate advertising programs. As an Amazon Associate, Kavout or its partners earn from qualifying purchases from affiliate links. We also participate in other affiliate and advertising programs that provide a means for us to earn advertising fees by advertising and linking to third-party websites.